JAMA Neurology published the following article in 2012. Another
person living with Kennedy’s Disease recommended the article to me. The paper
does a good job of explaining the condition to the layperson.
Masahisa Katsuno, MD, PhD; Haruhiko
Banno, MD, PhD; Keisuke Suzuki, MD, PhD; Hiroaki Adachi, MD, PhD; Fumiaki
Tanaka, MD, PhD; Gen Sobue, MD, PhD
“Spinal and
bulbar muscular atrophy (SBMA), or Kennedy disease, is an adult-onset lower
motor neuron disease characterized by slowly progressive muscle weakness and
atrophy. The disease is caused by the expansion of a trinucleotide CAG repeat
encoding a polyglutamine tract within the first exon of the androgen receptor
(AR) gene. During the 2 decades since the discovery of the AR gene mutation in
SBMA, basic and clinical research have deepened our understanding of the
disease phenotype and pathophysiology. Spinal and bulbar muscular atrophy exclusively
affects men, whereas women homozygous for the AR mutation do not fully develop
the disease. The ligand-dependent nuclear accumulation of pathogenic AR protein
is central to the pathogenesis, although additional steps, eg, DNA binding and
interdomain interactions of AR, are required for toxicity. Downstream molecular
events, eg, transcriptional dysregulation, axonal transport disruption, and
mitochondrial dysfunction, are implicated in the neurodegeneration in SBMA.
Pathogenic AR-induced myopathy also contributes to the degeneration of motor
neurons. Several potential therapies, including hormonal manipulation, have
emerged from animal studies, some of which have been tested in clinical trials.”
Follow the title's link to the full article.
Follow the title's link to the full article.
No comments:
Post a Comment
Please feel free to comment. By taking a moment to share your thoughts you add much to these articles. The articles then become more than just something I said or believe. In addition, by adding a comment, you might just be helping the next reader by sharing your opinion, experience, or a helpful tip. You can comment below or by sending me an email. I look forward to hearing from you.